摘要
为观察肝硬化患者外周血纤溶功能变化。分别用发色底物法、酶联免疫吸附法测定 6 8例肝硬化 ,37例正常人外周血的组织型纤溶酶原激活物活性 (t PA :A)及其抗原 (t -PA :Ag) ,纤溶酶原激活物抑制物活性 (PAI-A)及D -二聚体。结果显示 :肝硬化患者纤溶指标t -PA :A、t -PA :Ag及D -二聚体显著高于正常人 ,失代偿者明显高于代偿者。而PAI-A变化与其相反。提示 :肝硬化患者外周血存在不同程度的纤溶活性增高 ,测定上述指标对估计肝功能及临床用药有指导意义。
WT5”BZ] To investigate the function of fibrinolysis in patients with cirrhosis, Plasminogen activator inhibitor-A(PAI-A)、tissue-type plasminogen activator-A(t-PA:A)and t-PA:Ag were assayed by chromogenic assay, D-dimer was assayed by ELISA.These targets were assayed in 37 healthy volunteers and 68 patients with cirrhosis (36 in compensatory stage and 32 in incompensatory stage).Results:t-PA:A、t-PA:Ag and D-dimer in serum concentration were significant higher in cirrhosis group than healthy volunteers group, they were also significant higher in incompensatory cirrhosis group than compensatory cirrhosis group, PAI-A was by contrary in incompensotory cirrhosis group, compensatory cirrhosis group and healthy volunteers group. Conclusions:Hyperfibrinolysis is signifirance in cirrhosis patients in different degree. [WT5”HZ]
出处
《临床肝胆病杂志》
CAS
北大核心
2000年第1期35-36,共2页
Journal of Clinical Hepatology
